Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine

Tania Bubela, Amrita Mishra, Debra J Mathews

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The complexities of the translational pathways for stem cell research point to the need to bolster incentives for collaborative, multinational, multidisciplinary, and multi-sectorial research and development, in particular, harnessing the respective strengths of academic, biotechnology, and pharmaceutical sectors. Collaborations, especially within the pre-competitive environment, are theorized to lead to the more efficient use of resources and knowledge through the reduction of negotiating costs associated with an abundance of intellectual property rights (IPRs), the avoidance of duplicative research within a secretive environment, and the use of standard research tools and methods, supported by repositories for data and materials. This chapter explores models to facilitate such collaborations in stem cell research. The focus is on enablement, through creative management of IPRs, of pre-competitive research with academia at its core. The chapter first provides an overview of the patent landscape in stem cell research. This allows for an understanding of claims that may block follow-on innovation and of areas where numerous overlapping claims make it difficult to define all of the IPRs within a given area and to therefore negotiate freedom to operate. The chapter then describes emerging models in drug discovery and animal model communities that facilitate collaborations in the pre-competitive research environment. Such models range from the establishment of databases and repositories for research reagents to public-private partnerships that harness the capabilities and strengths of multiple sectors. The following section gives examples of such initiatives within stem cell research. The chapter concludes with an analysis of legal barriers to pre-competitive research collaborations, namely, restrictive licensing policies, and discusses incentive structures and best practices for facilitating collaborative, pre-competitive stem cell research.

Original languageEnglish (US)
Title of host publicationRegenerative Medicine Ethics: Governing Research and Knowledge Practices
PublisherSpringer New York
Pages67-87
Number of pages21
Volume9781461490623
ISBN (Print)9781461490623, 1461490618, 9781461490616
DOIs
StatePublished - Oct 1 2014

Fingerprint

Regenerative Medicine
Stem Cell Research
Intellectual Property
Ownership
Research
Stem cells
Intellectual property
Motivation
Public-Private Sector Partnerships
Negotiating
Drug Discovery
Licensure
Biotechnology
Practice Guidelines
Animal Models
Databases
Costs and Cost Analysis
Pharmaceutical Preparations
Animals
Innovation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Bubela, T., Mishra, A., & Mathews, D. J. (2014). Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine. In Regenerative Medicine Ethics: Governing Research and Knowledge Practices (Vol. 9781461490623, pp. 67-87). Springer New York. https://doi.org/10.1007/978-1-4614-9062-3_3

Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine. / Bubela, Tania; Mishra, Amrita; Mathews, Debra J.

Regenerative Medicine Ethics: Governing Research and Knowledge Practices. Vol. 9781461490623 Springer New York, 2014. p. 67-87.

Research output: Chapter in Book/Report/Conference proceedingChapter

Bubela, T, Mishra, A & Mathews, DJ 2014, Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine. in Regenerative Medicine Ethics: Governing Research and Knowledge Practices. vol. 9781461490623, Springer New York, pp. 67-87. https://doi.org/10.1007/978-1-4614-9062-3_3
Bubela T, Mishra A, Mathews DJ. Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine. In Regenerative Medicine Ethics: Governing Research and Knowledge Practices. Vol. 9781461490623. Springer New York. 2014. p. 67-87 https://doi.org/10.1007/978-1-4614-9062-3_3
Bubela, Tania ; Mishra, Amrita ; Mathews, Debra J. / Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine. Regenerative Medicine Ethics: Governing Research and Knowledge Practices. Vol. 9781461490623 Springer New York, 2014. pp. 67-87
@inbook{87aeefe964e949bcb6c71ce5eae64186,
title = "Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine",
abstract = "The complexities of the translational pathways for stem cell research point to the need to bolster incentives for collaborative, multinational, multidisciplinary, and multi-sectorial research and development, in particular, harnessing the respective strengths of academic, biotechnology, and pharmaceutical sectors. Collaborations, especially within the pre-competitive environment, are theorized to lead to the more efficient use of resources and knowledge through the reduction of negotiating costs associated with an abundance of intellectual property rights (IPRs), the avoidance of duplicative research within a secretive environment, and the use of standard research tools and methods, supported by repositories for data and materials. This chapter explores models to facilitate such collaborations in stem cell research. The focus is on enablement, through creative management of IPRs, of pre-competitive research with academia at its core. The chapter first provides an overview of the patent landscape in stem cell research. This allows for an understanding of claims that may block follow-on innovation and of areas where numerous overlapping claims make it difficult to define all of the IPRs within a given area and to therefore negotiate freedom to operate. The chapter then describes emerging models in drug discovery and animal model communities that facilitate collaborations in the pre-competitive research environment. Such models range from the establishment of databases and repositories for research reagents to public-private partnerships that harness the capabilities and strengths of multiple sectors. The following section gives examples of such initiatives within stem cell research. The chapter concludes with an analysis of legal barriers to pre-competitive research collaborations, namely, restrictive licensing policies, and discusses incentive structures and best practices for facilitating collaborative, pre-competitive stem cell research.",
author = "Tania Bubela and Amrita Mishra and Mathews, {Debra J}",
year = "2014",
month = "10",
day = "1",
doi = "10.1007/978-1-4614-9062-3_3",
language = "English (US)",
isbn = "9781461490623",
volume = "9781461490623",
pages = "67--87",
booktitle = "Regenerative Medicine Ethics: Governing Research and Knowledge Practices",
publisher = "Springer New York",

}

TY - CHAP

T1 - Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine

AU - Bubela, Tania

AU - Mishra, Amrita

AU - Mathews, Debra J

PY - 2014/10/1

Y1 - 2014/10/1

N2 - The complexities of the translational pathways for stem cell research point to the need to bolster incentives for collaborative, multinational, multidisciplinary, and multi-sectorial research and development, in particular, harnessing the respective strengths of academic, biotechnology, and pharmaceutical sectors. Collaborations, especially within the pre-competitive environment, are theorized to lead to the more efficient use of resources and knowledge through the reduction of negotiating costs associated with an abundance of intellectual property rights (IPRs), the avoidance of duplicative research within a secretive environment, and the use of standard research tools and methods, supported by repositories for data and materials. This chapter explores models to facilitate such collaborations in stem cell research. The focus is on enablement, through creative management of IPRs, of pre-competitive research with academia at its core. The chapter first provides an overview of the patent landscape in stem cell research. This allows for an understanding of claims that may block follow-on innovation and of areas where numerous overlapping claims make it difficult to define all of the IPRs within a given area and to therefore negotiate freedom to operate. The chapter then describes emerging models in drug discovery and animal model communities that facilitate collaborations in the pre-competitive research environment. Such models range from the establishment of databases and repositories for research reagents to public-private partnerships that harness the capabilities and strengths of multiple sectors. The following section gives examples of such initiatives within stem cell research. The chapter concludes with an analysis of legal barriers to pre-competitive research collaborations, namely, restrictive licensing policies, and discusses incentive structures and best practices for facilitating collaborative, pre-competitive stem cell research.

AB - The complexities of the translational pathways for stem cell research point to the need to bolster incentives for collaborative, multinational, multidisciplinary, and multi-sectorial research and development, in particular, harnessing the respective strengths of academic, biotechnology, and pharmaceutical sectors. Collaborations, especially within the pre-competitive environment, are theorized to lead to the more efficient use of resources and knowledge through the reduction of negotiating costs associated with an abundance of intellectual property rights (IPRs), the avoidance of duplicative research within a secretive environment, and the use of standard research tools and methods, supported by repositories for data and materials. This chapter explores models to facilitate such collaborations in stem cell research. The focus is on enablement, through creative management of IPRs, of pre-competitive research with academia at its core. The chapter first provides an overview of the patent landscape in stem cell research. This allows for an understanding of claims that may block follow-on innovation and of areas where numerous overlapping claims make it difficult to define all of the IPRs within a given area and to therefore negotiate freedom to operate. The chapter then describes emerging models in drug discovery and animal model communities that facilitate collaborations in the pre-competitive research environment. Such models range from the establishment of databases and repositories for research reagents to public-private partnerships that harness the capabilities and strengths of multiple sectors. The following section gives examples of such initiatives within stem cell research. The chapter concludes with an analysis of legal barriers to pre-competitive research collaborations, namely, restrictive licensing policies, and discusses incentive structures and best practices for facilitating collaborative, pre-competitive stem cell research.

UR - http://www.scopus.com/inward/record.url?scp=84929676374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929676374&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-9062-3_3

DO - 10.1007/978-1-4614-9062-3_3

M3 - Chapter

AN - SCOPUS:84929676374

SN - 9781461490623

SN - 1461490618

SN - 9781461490616

VL - 9781461490623

SP - 67

EP - 87

BT - Regenerative Medicine Ethics: Governing Research and Knowledge Practices

PB - Springer New York

ER -